DP4CYCH4MT Uses, Dosage, Side Effects and more

DP4CYCH4MT is under investigation in clinical trial NCT02688101 (Dose-finding and Pharmacokinetic Study of DpC, Administered Orally to Patients With Advanced Solid Tumors).

Trade Name DP4CYCH4MT
Generic Di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone
Di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone Other Names DP4CYCH4MT
Type
Formula C19H23N5S
Weight Average: 353.49
Monoisotopic: 353.167416935
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share